150+ clients worldwide · Offices in India & UAE InsightsSupport
Phibuzz
Healthcare & Pharma

Pharma marketing in India: growing responsibly under UCPMP 2024

Indian pharma companies are among the world's most important suppliers of medicines, yet many still rely on traditional field promotion alone. Under the Uniform Code for Pharmaceutical Marketing Practices 2024, marketing has to be both effective and ethical. Here is what the code covers and how to build a modern, compliant growth engine.

Quick answer: The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, notified by India's Department of Pharmaceuticals on 12 March 2024, governs how pharma companies promote medicines, including promotional materials, medical representatives, samples and interactions with healthcare professionals, and restricts gifts and travel for doctors. Complaints go to ethics committees within pharma associations, with appeals to an apex committee. Within these rules, the strongest growth levers are brand credibility, scientific content, B2B digital marketing and exhibitions.

This article is general guidance, not legal advice. Always review campaigns with your regulatory and legal teams.

What UCPMP 2024 covers

The code, issued by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, replaces the earlier 2014 code. It covers medical representatives, textual and audio-visual promotional materials, samples, gifts and the procedure for complaints and penalties. (Medical Dialogues)

  • Ethics committees: each pharmaceutical association must set up an Ethics Committee for Pharma Marketing Practices (ECPMP) to handle complaints.
  • Appeals: decisions can be appealed to an apex committee headed by the Secretary of the Department of Pharmaceuticals.
  • No inducements: the government has stressed that gifts and travel facilities for doctors are not permitted.
  • Medical devices: a separate code, the Uniform Code for Marketing Practices in Medical Devices (UCMPMD) 2024, applies to device companies.

A compliant growth strategy for pharma companies

1. Build corporate and product credibility

Quality certifications, manufacturing capabilities, regulatory approvals and leadership expertise should be clear across your website, LinkedIn and collateral.

2. Invest in scientific, evidence-based content

Balanced, referenced content for healthcare professionals, such as clinical summaries and educational resources, supports trust without inducements.

3. Grow B2B and export demand digitally

API suppliers, CDMOs and formulation exporters can reach distributors and partners worldwide through SEO, AI search visibility, LinkedIn and targeted campaigns. See our Middle East pharma marketing playbook.

4. Make exhibitions work harder

CPHI events and regional healthcare shows such as WHX Dubai are key moments for partnerships. Plan meetings, content and follow-up in advance with our healthcare events calendar.

5. Build a review process

Create a marketing review workflow with regulatory, medical and legal sign-off for every promotional asset.

Frequently asked questions

What is UCPMP 2024?
UCPMP 2024 is the Uniform Code for Pharmaceutical Marketing Practices notified by India's Department of Pharmaceuticals on 12 March 2024. It governs promotional practices, including materials, samples, medical representatives and interactions with healthcare professionals.
Can pharma companies give gifts to doctors in India?
The government has called for strict compliance with UCPMP 2024, stressing that gifts and travel facilities for doctors are not permitted. Review specific activities with your compliance team.
Can pharma companies use digital marketing in India?
Yes, within the rules. Corporate branding, B2B and export marketing, scientific content and HCP education are common, but promotion of prescription medicines must follow UCPMP 2024 and other applicable laws.

Build a pharma brand partners and doctors trust

Phibuzz helps Indian and Gulf pharma companies build credible brands, B2B demand and exhibition programmes. Request a pharma marketing plan.

Written by

Phibuzz Editorial Team

Brand & growth strategists · India and UAE

The Phibuzz Editorial Team brings together our brand strategists, SEO and AI search specialists, performance marketers and event marketing leads in Mohali, India and Ajman, UAE. We write from hands-on work with 150+ clients across healthcare, AI and technology, textiles, manufacturing, B2B and D2C, and we research every date, rule and figure against official sources before publishing.

← Back to Insights
Free download

The AI Search Playbook 2026

25 practical steps to get your brand found on Google and cited by ChatGPT, Gemini, Perplexity and Google AI Overviews. An 8-page PDF checklist with a self-scoring system.

  • Foundations, content, authority, technical and measurement
  • Self-scoring checklist for your team
  • Built from our AEO & GEO client work

Instant download. No spam, unsubscribe any time.

Let's talk

Ready to grow with Phibuzz?

More than 150 organisations have trusted Phibuzz to shape how the world sees them. We would welcome the opportunity to do the same for you.

The Phibuzz Brief

Brand and growth insights, once a month.

AI search updates, brand strategy and campaign ideas from our team in India and the UAE. Written for founders and marketing leaders.

One email a month. No spam.